Stay updated on Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial
Sign up to get notified when there's something new on the Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial page.

Latest updates to the Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page’s software revision marker was updated from v3.5.2 to v3.5.3, indicating a platform/version change rather than a modification to the trial’s record history.SummaryDifference0.1%

- Check16 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check45 days agoChange DetectedAdded a new record version v3.5.0 and removed v3.4.3 from the history.SummaryDifference0.1%

- Check52 days agoChange DetectedA new revision entry v3.4.3 was added and the previous revision v3.4.2 was removed from the history.SummaryDifference0.1%

- Check80 days agoChange DetectedAdded Revision: v3.4.2 to the history log and removed older notices including the lapse in government funding message and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check88 days agoChange DetectedNotice added about government funding and the latest system revision to v3.4.1. The previous revision v3.4.0 was removed.SummaryDifference0.4%

Stay in the know with updates to Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial page.